Current concepts: Osteomyelitis

New England Journal of Medicine

Volumn 336, Issue 14, 1997, Pages 999-1007

  Lew, Daniel P ^a   Waldvogel, Francis A ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFAZOLIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; IMIPENEM; NAFCILLIN; PENICILLIN G; QUINOLONE DERIVATIVE; TEICOPLANIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; BACTERIUM IDENTIFICATION; CLINICAL EXAMINATION; DRUG CHOICE; HUMAN; ORTHOPEDIC SURGERY; OSTEOMYELITIS; PATHOGENESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; NUCLEAR MAGNETIC RESONANCE IMAGING;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; HUMANS; MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS;

EID: 0031550934     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199704033361406     Document Type: Review

References (62)

1. Grmek M. Les maladies à l'aube de la civilisation occidentale: recherches sur la réalité pathologique dans le monde grec préhistorique, archaique, et classique. Paris: Payot, 1983:190-1.
2. Waldvogel FA, Vasey H. Osteomyelitis: the past decade. N Engl J Med 1980;303:360-70.
3. Waldvogel FA, Medoff G, Swartz MN. Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. N Engl J Med 1970;282:198-206, 260-6, 316-22.
4. Jauregui LE. Diagnosis and management of bone infections. New York: Marcel Dekker, 1995.
5. Norden CW. Lessons learned from animal models of osteomyelitis. Rev Infect Dis 1988;10:103-10.
6. Belmatoug N, Crémieux AC, Bleton R, et al. A new model of experimental prosthetic joint infection due to methicillin-resistant Staphylococcus aureus: a microbiologic, histopathologic, and magnetic resonance imaging characterization. J Infect Dis 1996;174:414-7.
7. Zimmerli W, Lew PD, Waldvogel FA. Pathogenesis of foreign body infection: evidence for a local granulocyte defect. J Clin Invest 1984;73: 1191-200.
8. Hermann M, Vaudaux PE, Pittet D, et al. Fibronectin, fibrinogen and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis 1988;158:693-701.
9. Patti JM, Boles JO, Höök M. Identification and biochemical characterization of the ligand binding domain of the collagen adhesin from Staphylococcus aureus. Biochemistry 1993;32:11428-35.
10. Greene C, Vaudaux PE, Francois P, Proctor RA, McDevitt D, Foster TJ. A low fibronectin-binding mutant of Staphylococcus aureus 879R4S has Tn918 inserted into its single fnb gene. Microbiology 1996;142:2153-60.
11. Fischer B, Vaudaux P, Magnin M, et al. A novel animal model for studying the molecular mechanisms of bacterial adhesion to bone-implanted metallic devices: role of fibronectin in Staphylococcus aureus adhesion. J Orthop Res 1996;14:1914-20.
12. Hudson MC, Ramp WK, Nicholson NC, Williams AS, Nousiainen MT. Internalization of Staphylococcus aureus by cultured osteoblasts. Microbial Pathogenesis 1995;19:409-19.
13. Proctor RA, van Langevelde P, Kristjansson M, Maslow JN, Arbeit RD. Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin Infect Dis 1995;20:95-102.
14. Chuard C, Lucet JC, Rohner P, et al. Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials. J Infect Dis 1991;163:1369-73.
15. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling: emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995;332:305-11.
16. Nair SP, Meghji S, Wilson M, Reddi K, White P, Henderson B. Bacterially induced bone destruction: mechanisms and misconceptions. Infect Immun 1996;64:2371-80.
17. Mader JT, Norden C, Nelson JD, Calandra GB. Evaluation of new anti-infective drugs for the treatment of osteomyelitis in adults: Infectious Diseases Society of America and the Food and Drug Administration. Clin Infcct Dis 1992;15:Suppl 1:S155-S161.
18. Mackowiak PA, Jones SR, Smith JW. Diagnostic value of sinus-tract cultures in chronic osteomyelitis. JAMA 1978;239:2772-5.
19. Howard CB, Einhorn M, Dagan R, Yagupski P, Porat S. Fine needle bone biopsy to diagnose osteomyelitis. J Bone Joint Surg Br 1994;76:311-4.
20. Darouiche RO, Landon GC, Kilma M, Musher DM, Markowski J. Osteomyelitis associated with pressure sores. Arch Intern Med 1994;154:753-8.
21. Manion SS, LaValley AL. Radiographic diagnosis of bone and joint infection. In: Jauregui LE, ed. Diagnosis and management of bone infections. New York: Marcel Dekker, 1995:325-72.
22. Gold RH, Hawkins RA, Katz RD. Bacterial osteomyelitis: findings on plain radiography, CT, MR, and scintigraphy. AJR Am J Roentgenol 1991; 157:365-70.
23. Tumeh SS, Tohmeh AG. Nuclear medicine techniques in septic arthritis and osteomyelitis. Rheum Dis Clin North Am 1991;17:559-83.
24. 111In is superior to magnetic resonance imaging in diagnosis of clinically unsuspected osteomyelitis in diabetic foot ulcers. Diabetes Care 1992;15: 1527-30.
25. Oyen WJ, Claessens RA, van Horn JR, van der Meer JW, Corstens FH. Scintigraphic detection of bone and joint infections with indium-111-labeled nonspecific polyclonal human immunoglobulin G. J Nucl Med 1990;31:403-12.
26. Morrison WB, Schweitzer ME, Bock GW, et al. Diagnosis of osteomyelitis: utility of fat-suppressed contrast-enhanced MR imaging. Radiology 1993;189:251-7.
27. D'Hoore K, Hoogmartens M. Vertebral aspergillosis: a case report and review of the literature. Acta Orthop Belg 1993;59:306-14.
28. Pirofsky JG, Huang CT, Waites KB. Spinal osteomyelitis due to Mycobacterium avium-intracellulare in an elderly man with steroid-induced osteoporosis. Spine 1993;18:1926-9.
29. Tang C. Successful treatment of Candida albicans osteomyelitis with fluconazole. J Infect 1993;26:89-92.
30. Torda AJ, Gottlieb T, Bradbury R. Pyogenic vertebral osteomyelitis: analysis of 20 cases and review. Clin Infect Dis 1995;20:320-8.
31. Norden C, Nelson JD, Mader JT, Calandra GB. Evaluation of new anti-infective drugs for the treatment of infections of prosthetic hip joints: Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992;15:Suppl 1:S177-S181.
32. Caputo GM, Cavanagh PR, Ulbrecht JS, Gibbons GW, Karchmer AW. Assessment and management of foot disease in patients with diabetes. N Engl J Med 1994;331:854-60.
33. Grayson ML, Gibbons GW, Balogh K, Levin E, Karchmer AW. Probing to bone in infected pedal ulcers: a clinical sign of underlying osteomyelitis in diabetic patients. JAMA 1995;273:721-3.
34. Gold RH, Tong DJF, Crim JR, Seeger LL. Imaging the diabetic foot. Skeletal Radiol 1995;24:563-71.
35. Norden CW. Antibiotic prophylaxis in orthopedic surgery. Rev Infect Dis 1991;13:Suppl 10:S842-S846.
36. Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992;326:281-6.
37. Dellinger EP, Caplan ES, Weaver LD, et al. Duration of preventive antibiotic administration for open extremity fractures. Arch Surg 1988;123: 333-9.
38. Boxma H, Broekhuizen T, Patka P, Oosting H. Randomised controlled trial of single-dose antibiotic prophylaxis in surgical treatment of closed fractures: the Dutch Trauma Trial. Lancet 1996;347:1133-7.
39. Patzakis MJ, Harvey JP Jr, Ivler D. The role of antibiotics in the management of open fractures. J Bone Joint Surg Am 1974;56:532-41.
40. Gustilo RB, Anderson JT. Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones: retrospective and prospective analyses. J Bone Joint Surg Am 1976;58:453-8.
41. Lew DP, Pittet D, Waldvogel FA. Infections that complicate the insertion of prosthetic devices. In: Mayhall CG, ed. Hospital epidemiology and infection control. Baltimore: Williams & Wilkins, 1996:731-48.
42. Klenerman L, Seal D, Sullens K. Combined prophylactic effect of ultraclean air and cefuroxime for reducing infection in prosthetic surgery. Acta Orthop Belg 1991;57:19-24.
43. Charnley J. Postoperative infection after total hip replacement with special reference to air contamination in the operating room. Clin Orthop 1972;87:167-87
44. Lidwell OM, Lowbury EJL, Whyte W, Blowers R, Stanley SJ, Lowe D. Effect of ultraclean air in operating rooms on deep sepsis in the joint after total hip or knee replacement: a randomised study. BMJ 1982;285: 10-4.
45. Hill C, Flamant R, Mazas F, Evrard J. Prophylactic cefazotin versus placebo in total hip replacement: report of a multicentre double-blind randomised trial. Lancet 1981;1:795-6.
46. Nelson JD. A critical review of the role of oral antibiotics in the management of hematogenous osteomyelitis. In: Remington RS, Swartz MN, eds. Clinical topics in infectious disease. Vol. 4. New York: McGraw-Hill, 1996:64-74.
47. Gentry LO. Oral antimicrobial therapy for osteomyelitis. Ann Intern Med 1991;114:986-7.
48. Lew DP, Waldvogel FA. Quinolones and osteomyelitis: state-of-the-art. Drugs 1995;49:Suppl 2:100-11.
49. Schaad HJ, Chuard C, Vaudaux P, Waldvogel FA, Lew DP. Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1994;38: 1703-10.
50. Graninger W, Wenisch C, Wiesinger E, Menschik M, Karimi J, Presterl E. Experience with outpatient intravenous teicoplanin therapy for chronic osteomyelitis. Eur J Clin Microbiol Infect Dis 1995;14:643-7.
51. Nelson CL, Evans RP, Blaha JD, Calhoun J, Henry SL, Patzakis MJ. A comparison of gentamicin-impregnated polymethylmethacrylate bead implantation to conventional parenteral antibiotic therapy in infected total hip and knee arthroplasty. Clin Orthop 1993;295:96-101.
52. Reese JH, Barrio J. Surgical approaches to the management of osteomyelitis. In: Jauregui LE, ed. Diagnosis and management of bone infections. New York: Marcel Dekker, 1995:425-9.
53. Eckardt JJ, Wirganowicz PZ, Mar T. An aggressive surgical approach to the management of chronic osteomyelitis. Clin Orthop 1994;298:229-39.
54. Papineau LJ, Alfageme A, Dalcourt JP, Pilon L. Ostéomyélite chronic: excision et greffe de spongieux à l'air libre après mises à plat extensives. Int Orthop 1979;3:165-76.
55. Mathes SJ. The muscle flap for management of osteomyelitis. N Engl J Med 1982;306:294-5.
56. Gordon L, Chiu EJ. Treatment of infected non-unions and segmental defects of the tibia with staged microvascular muscle transplantation and bone-grafting. J Bone Joint Surg Am 1988;70:377-86.
57. Weiland AJ, Moore JR, Daniel RK. The efficacy of free tissue transfer in the treatment of osteomyelitis. J Bone Joint Surg Am 1984;66:181-93.
58. Green SA. Osteomyelitis: the Ilizarov perspective. Orthop Clin North Am 1991;22:515-21.
59. Sowa DT, Weiland AJ. Clinical applications of vascularized bone autografts. Orthop Clin North Am 1987;18:257-73.
60. Drancourt M, Stein A, Argenson JN, Zannier A, Curvale G, Raoult D. Oral rifampin plus ofloxacin for treatment of Staphylacoccus-infected orthopedic implants. Antimicrob Agents Chemother 1993;37:1214-8.
61. Widmer AF, Gaechter A, Ochsner PE, Zimmerli W. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin Infect Dis 1992;14:1251-3.
62. Eckman MH, Greenfield S, Mackey WC, et al. Foot infections in diabetic patients: decision and cost-effectiveness analyses. JAMA 1995;273: 712-20.